Several coronavirus vaccine developers in China have readied their facilities for mass production, even though the medicine is still undergoing clinical trials and has no market approval yet. Once found and approved, the Covid-19 vaccines will be in high demand for use in efforts to control the worldwide coronavirus pandemic. The facilities in the Chinese capital Beijing could produce as many as 300 million doses a year.